arrow
Z

Zili Hu

Department of Liver Surgery
H指数:14
被引数:476

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment (vol 23, 186, 2024)

YTHDF2在肿瘤周肝细胞中通过CX3CL1介导的CD8+ T细胞募集介导化疗诱导的抗肿瘤免疫应答(卷23,186,2024)

2025-01-310
OA
Laparoscopic Hepatectomy versus Open Hepatectomy After Conversion Therapy Using Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy for Patients with Initially Unresectable Hepatocellular Carcinoma

对于最初无法切除的肝细胞癌患者,使用经动脉化疗栓塞或肝动脉灌注化疗进行转化治疗后的腹腔镜肝切除术与开腹肝切除术的比较

2023-07-011
OAAI
Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis

肝动脉灌注化疗诱导治疗可增强仑伐替尼及PD-1抑制剂对伴门静脉癌栓的肝细胞癌患者的疗效。

2023-03-0926
PRE